ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

July 9-13, 2022. London, England, UK.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z
  • Abstract Number: PB1100

    Vaccine Induced Immune Thrombocytopenia and Thrombosis (VITT) external quality assessment (EQA) scheme results and interpretations from a joint UKNEQAS BC, SSC and ECAT VITT Survey May 2021.

    C. Reilly-Stitt1, A. Lowe1, I. Jennings2, S. Kitchen3, P. Meijer4, M. de Maat5, T. Backchoul6, I. Walker1

  • Abstract Number: PB0070

    Vaccine Induced Thrombotic Thrombocytopenia post Dose 2 ChAdOx1 nCoV19 vaccination: less severe but not void of catastrophic outcomes

    L. Clarke1, H. Tran2, J. Curnow3, J. Falconer4, S. Chunilal5, T. Brighton6, F. Passam7, C. Lee8, D. Donikian6, M. Kondo6, V. CHEN9

  • Abstract Number: VPB0135

    Vaccine-induced thrombotic thrombocytopenia (VITT) in COVID-19 vaccination: Demystified

    A. Singh1, C. Amrutha2, S. Vidyasagar2, N. Fatima3, S. Chauhan4

  • Abstract Number: OC 15.5

    Validating Direct Oral Anticoagulants (DOAC) for Use in Children by the Throm-PED DOAC Registry of the International Pediatric Thrombosis Network

    S. Holzhauer1, P. Monagle2, C. Male3, R. Bhat4, M. Bordbar5, R. Natesirinilkul6, S. Saini7, M. Simpson8, C. van Ommen9, L. Raffini10

  • Abstract Number: OC 54.2

    Validation of a Hospital-Acquired Venous Thrombosis Risk Assessment Model: The Medical Inpatient Thrombosis and Hemostasis (MITH) Study

    N. Zakai1, K. Wilkinson2, A. Sparks2, I. Koh3, N. Roetker4, A. Repp2, R. Thomas2, J. Schaefer5, N. Smith6, C. Holmes7, C. Hooper8, M. Cushman9

  • Abstract Number: OC 24.2

    VALIDATION OF A TREATMENT DECISION ALGORITHM FOR THE USE OF ANDEXANET ALFA IN ACUTE LIFE-THREATENING BLEEDING FROM DIRCT FACTOR Xa INHIBITORS

    J. Beyer-Westendorf1, J. Koscielny2

  • Abstract Number: PB1396

    Validation of clinical reference ranges for viscoelastometric assessment of haemostasis (TEG® 6S) and standard laboratory tests in obstetric patients

    E. Crossland, D. White, J. Bamber, R. Tassell, M. Besser, E. Symington, M. Robinson, W. Thomas, S. MacDonald

  • Abstract Number: PO0073

    Validation of DOAC Dipstick in obese patients anticoagulated with direct oral anticoagulants. Rationale and study design

    t. bucci1, D. Pastori2, d. menichelli2, F. Violi3, J. Harenberg4, P. Pignatelli5

  • Abstract Number: PB0246

    Validation of Thai Pediatric Bleeding Assessment Tools Mobile Application for Diagnosis of Pediatric Bleeding Disorders

    A. SERMCHEEP1, N. Sirachainan2, D. Songdej3, A. Chuansumrit4, P. Wongwerawattanakoon5

  • Abstract Number: PB0653

    Validation of the Hemophilia Treatment Experience Measure (Hemo-TEM): a New Haemophilia-specific Patient-reported Outcome Measure

    M. Brod1, D. Bushnell2, J. Skov Neergaard3, A. Busk3

  • Abstract Number: PB0994

    Validation of the IMPROVE Hospital-Acquired Bleeding Risk Assessment Model in The Medical Inpatients Thrombosis and Hemostasis Study (MITH) Population

    K. Wilkinson1, A. Sparks1, M. Gergi1, A. Repp1, H. Al-Samkari2, N. Roetker3, N. Zakai4

  • Abstract Number: OC 54.3

    Validation of the IMPROVE Hospital-Acquired Venous Thrombosis Risk Assessment Model in The Medical Inpatients Thrombosis and Hemostasis Study (MITH) Population

    A. Sparks1, K. Wilkinson1, A. Repp1, A. Li2, R. Thomas1, N. Roetker3, N. Zakai4

  • Abstract Number: PB0243

    Validation of the PLTEMA10 in Cardiac Surgery (CS) neonatal population weighing less than 5 Kg

    M. Lopez1, F. Mileo2, P. Rossi2, T. Vainstein2, L. Barrera3, M. Martinuzzo4

  • Abstract Number: PO0041

    Value of rotational thrombelastometry in perioperative management of patients with inherited coagulopathy during surgery

    M. Sterankova1, T. Simurda2, J. Zolkova3, M. Brunclikova3, J. Stasko3, I. Skornova3, Z. Cibula4, L. Nečas5

  • Abstract Number: PB0949

    Variability in thrombophilia testing in large international physician survey

    M. Ellis1, O. Avnery1, B. Hunt2

  • Abstract Number: VPB0435

    Vascular involvement in Behçet’s disease

    A. Baya Chatti1, S. Skhiri2, A. Guiga2, W. Ben Yahia2, A. Atig2, N. Ghannouchi2

  • Abstract Number: VPB0741

    Vasculopathy as an Atypical Manifestation of Paroxysmal Nocturnal Hemoglobinuria: a Case Report

    S. Candrianita, L. Hamijoyo, S. Prodjosoewojo, E. Martanto

  • Abstract Number: VPB0634

    Veno-occlusive disease in pediatric patients after stem cell transplant is associated with impaired fibrinolysis

    S. Hammer1, V. Schneider2, M. Döring2, K. Althaus3, T. Backchoul4

  • Abstract Number: OC 25.1

    Venous and Arterial Thromboembolism after Incident Colorectal Cancer in the Netherlands: Incidence, Predictors, and Prognosis

    R. Anijs1, Q. Chen2, W. Lijfering2, S. Cannegieter2

  • Abstract Number: OC 25.3

    Venous thromboembolism and cancer. Incidence and sex difference.

    K. Glise Sandblad1, J. Sörbo2, P. Karlsson3, A. Rosengren4, P. Hansson5

  • Abstract Number: OC 42.4

    Venous thromboembolism associated with oestrogen-containing contraceptives versus any hormonal risk factor: a comparison of recurrence rates

    J. Knijp1, H. Wiegers2, N. van Es2, M. Coppens3, S. Moll4, F. Klok5, S. Middeldorp6

  • Abstract Number: OC 08.3

    Venous thromboembolism in a large series of pediatric patients with acute lymphoblastic leukemia. Risk factors and use of prophylaxis.

    R. Berrueco1, A. Ruiz-Llobet2, S. Gassiot3, E. Sarrate4, J. Zubicaray5, J. Dapena6, A. Menárguez7, M. Panesso7, C. Montoya8, J. Vagace9, J. Molina10, M. García-Morín11, M. García-Abos12, M. Mendoza13, F. Lendinez14, P. Palomo15, M. Tallón16, B. González17, E. Urrutia18, J. Serna19

  • Abstract Number: PB0937

    Venous Thromboembolism in Bladder Cancer:Scope of the Problem and Patients’ Perspectives(VTE-BC)

    O. Abdullah1, A. Young2, D. Parashar3, A. Ignatowicz4

  • Abstract Number: PB1323

    Venous thromboembolism in obese patients: a ten-year experience

    B. Wee1, B. Lui1, P. Ho2, H. Lim1

  • Abstract Number: PB1354

    Venous Thromboembolism Prophylaxis Use by Pediatric Orthopedic Surgeons in Canada

    J. Curwin1, W. MacNevin1, R. El-Hawary2, K. Kulkarni2

  • Abstract Number: PB0454

    Venous thromboembolism reoccurrence during factor Xa inhibitors in young patients associates with thoracic outlet syndrome and development of chronic thromboembolic pulmonary hypertension

    M. Kaksonen1, M. Pentikäinen2, P. Simonen2, R. Lassila3

  • Abstract Number: VPB1417

    Venous thromboprophylaxis in 108 hospitalized pregnant women with COVID-19: Experience of a Public Hospital in Argentina from April 2020-July 2021.

    B. Grand1, M. Gonzalez Alcantara2, L. Voto2

  • Abstract Number: PB0956

    Venous thrombosis associated with combined oral contraceptives: role of intrinsic thrombin generation potential

    A. Rauch1, A. van Hylckama Vlieg2, F. Rosendaal3

  • Abstract Number: PB0631

    VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow

    G. Poolen1, M. van Moorsel2, C. Koekman1, S. Verhoef1, S. De Maat2, A. Barendrecht2, N. van Kleef1, J. Meijers3, R. Schiffelers4, C. Maas2, R. Urbanus5

  • Abstract Number: VPB0640

    Vinegar Produce t-PA from Human Endothelial Cells

    H. Sumi1, T. Mitsuo2, Y. Yanagisawa3, M. Imai1

  • Abstract Number: PB0621

    Virtually screening for novel small molecule inhibitors against the conformational landscape of coagulation factor XIII activation-path

    M. Islam1, S. Ramaraje Urs2, S. Singh3, H. Javed4, A. Paul George5, D. Imhof1, J. Oldenburg6, A. Biswas2

  • Abstract Number: PB0473

    Viscoelastic Testing to Guide Transfusion Management in Patients with End Stage Liver Disease: A Systematic Review and Meta-analysis

    M. Al Moosawi1, T. Hussaini2

  • Abstract Number: PB0734

    Visualization of Gliomas with Clot-binding Peptides

    C. Wolter1, L. Knowles2, S. Linsler3, S. Müller3, M. Jung4, E. Hermann5, J. Pilch6

  • Abstract Number: VPB1313

    VKORC1 -1639AA Genotype as a Possible Risk Factor for Venous Thromboembolism in Elderly Patients with FV Leiden Mutation

    S. Kapustin1, A. Chechulova2, J. Drijun1, Z. Sidorova1, V. Burakov1, V. Soroka3, V. Soldatenkov1, L. Papayan4

  • Abstract Number: OC 24.3

    VMX-C001 is an effective factor Xa inhibitor reversal agent and displays a favorable pharmacodynamic profile in animal models

    D. Verhoef1, T. Gomes2, H. Spronk3, G. Short4, P. Reitsma1

  • Abstract Number: PB0820

    Von willebrand disease in older patients

    C. Seaman

  • Abstract Number: PB0299

    Von Willebrand factor (VWF) multimer (MM) pattern in autoimmune thrombotic thrombocytopenic purpura (iTTP) during acute episodes and in remission

    T. Falter1, H. Roßmann2, C. Dekimpe3, L. de Waele4, E. Roose5, C. von Auer6, A. Degreif2, D. Marandiuc7, X. Messmer8, K. Lackner9, S. de Meyer10, K. Jurk11, K. Vanhoorelbeke10, B. Lämmle8

  • Abstract Number: PB0011

    Von Willebrand factor levels at 3 months after endothelial injury in Acute Coronary Syndrome: Single center experience.

    C. García Herce1, B. vegas2, S. Feijóo2, A. Alonso2, B. López2, P. roquero2, N. Acedo2

  • Abstract Number: VPB0842

    von Willebrand factor multimer analysis may predict the development of transplant-associated thrombotic microangiopathy

    S. Yamada1, M. Kubo2, H. Okumura3, M. Matsumoto2

  • Abstract Number: OC 46.4

    von Willebrand Factor-targeting thrombolysis to overcome tissue Plasminogen Activator resistance in vivo

    M. van Moorsel, C. Maas, S. De Maat

  • Abstract Number: VPB0836

    VWD Connect Foundation Severe Von Willebrand Disease Patient Registry

    J. M. Cesta1, A. Arapshian1, J. Cesta1, M. Gounder1, C. Walsh2, C. Morgenthaler1

Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley